Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)-A European Society of Organ Transplantation (ESOT) Consensus Statement

Overview

Journal Transpl Int

Specialty General Surgery

Date 2023 Oct 16

PMID 37841645

Authors

M Carbone

A Della Penna

C Mazzarelli

E De Martin

C Villard

A Bergquist

P D Line

J M Neuberger

S Al-Shakhshir

P J Trivedi

U Baumann

L Cristoferi

J Hov

B Fischler

N H Hadzic

D Debray

L DAntiga

N Selzner

L S Belli

S Nadalin

Affiliations

Soon will be listed here.

Abstract

Primary sclerosing cholangitis (PSC) is the classical hepatobiliary manifestation of inflammatory bowel disease (IBD) and a lead indication for liver transplantation (LT) in the western world. In this article, we present a Consensus Statement on LT practice, developed by a dedicated Guidelines' Taskforce of the European Society of Organ Transplantation (ESOT). The overarching goal is to provide practical guidance on commonly debated topics, including indications and timing of LT, management of bile duct stenosis in patients on the transplant waiting list, technical aspects of transplantation, immunosuppressive strategies post-transplant, timing and extension of intestinal resection and futility criteria for re-transplantation.

Citing Articles

2024: A Year in Review.

Berney T, Bellini M, Benning L, Bestard O, Masset C, Moeckli B Transpl Int. 2025; 37:14243.

PMID: 39877477 PMC: 11773336. DOI: 10.3389/ti.2024.14243.

Primary sclerosing cholangitis in children with inflammatory bowel disease: An ESPGHAN position paper from the Hepatology Committee and the IBD Porto group.

van Rheenen P, Kolho K, Russell R, Aloi M, Deganello A, Hussey S J Pediatr Gastroenterol Nutr. 2025; 80(2):374-393.

PMID: 39741383 PMC: 11788976. DOI: 10.1002/jpn3.12378.

Pulmonary hypertension post-liver transplant: A case report.

Alharbi S, Alturaif N, Mostafa Y, Alfhaid A, Albenmousa A, Alghamdi S World J Gastrointest Surg. 2024; 16(12):3875-3880.

PMID: 39734439 PMC: 11650223. DOI: 10.4240/wjgs.v16.i12.3875.

Outcome of Liver Retransplantation in Patients With Primary Sclerosing Cholangitis.

Molinaro A, Engesaeter L, Jorns C, Nordin A, Rasmussen A, Line P Liver Int. 2024; 45(1):e16214.

PMID: 39679639 PMC: 11648066. DOI: 10.1111/liv.16214.

Open Label Vancomycin in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Improved Colonic Disease Activity and Associations With Changes in Host-Microbiome-Metabolomic Signatures.

Quraishi M, Cheesbrough J, Rimmer P, Mullish B, Sharma N, Efstathiou E J Crohns Colitis. 2024; 19(2).

PMID: 39673746 PMC: 11831226. DOI: 10.1093/ecco-jcc/jjae189.

References

Carbone M, Neuberger J . Autoimmune liver disease, autoimmunity and liver transplantation. J Hepatol. 2013; 60(1):210-23. DOI: 10.1016/j.jhep.2013.09.020. View

Lightner A, Shen B . Perioperative use of immunosuppressive medications in patients with Crohn's disease in the new "biological era". Gastroenterol Rep (Oxf). 2017; 5(3):165-177. PMC: 5554387. DOI: 10.1093/gastro/gow046. View

Ferreira M, Ribeiro I, Hourneaux de Moura D, McCarty T, da Ponte Neto A, Farias G . Stent versus Balloon Dilation for the Treatment of Dominant Strictures in Primary Sclerosing Cholangitis: A Systematic Review and Meta-Analysis. Clin Endosc. 2021; 54(6):833-842. PMC: 8652153. DOI: 10.5946/ce.2021.052. View

Olsson R, Bjornsson E, Backman L, Friman S, Hockerstedt K, Kaijser B . Bile duct bacterial isolates in primary sclerosing cholangitis: a study of explanted livers. J Hepatol. 1998; 28(3):426-32. DOI: 10.1016/s0168-8278(98)80316-4. View

Goss J, Shackleton C, Farmer D, Arnaout W, Seu P, Markowitz J . Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience. Ann Surg. 1997; 225(5):472-81; discussion 481-3. PMC: 1190779. DOI: 10.1097/00000658-199705000-00004. View

Ong J, Bath M, Swift C, Al-Naeeb Y . Does colectomy affect the progression of primary sclerosing cholangitis? A systematic review and meta-analysis. Gastroenterol Hepatol Bed Bench. 2018; 11(4):277-283. PMC: 6204254. View

Trivedi P, Reece J, Laing R, Slaney E, Cooney R, Gunson B . The impact of ileal pouch-anal anastomosis on graft survival following liver transplantation for primary sclerosing cholangitis. Aliment Pharmacol Ther. 2018; 48(3):322-332. DOI: 10.1111/apt.14828. View

Alabraba E, Nightingale P, Gunson B, Hubscher S, Olliff S, Mirza D . A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts. Liver Transpl. 2009; 15(3):330-40. DOI: 10.1002/lt.21679. View

Deneau M, El-Matary W, Valentino P, Abdou R, Alqoaer K, Amin M . The natural history of primary sclerosing cholangitis in 781 children: A multicenter, international collaboration. Hepatology. 2017; 66(2):518-527. DOI: 10.1002/hep.29204. View

10.

Vannas M, Boyd S, Farkkila M, Arola J, Isoniemi H . Value of brush cytology for optimal timing of liver transplantation in primary sclerosing cholangitis. Liver Int. 2017; 37(5):735-742. DOI: 10.1111/liv.13276. View

11.

Klose J, Klose M, Metz C, Lehner F, Manns M, Klempnauer J . Outcome stagnation of liver transplantation for primary sclerosing cholangitis in the Model for End-Stage Liver Disease era. Langenbecks Arch Surg. 2014; 399(8):1021-9. PMC: 4232743. DOI: 10.1007/s00423-014-1214-6. View

12.

Martin F, Rossi R, Nugent F, Scholz F, Jenkins R, Lewis W . Surgical aspects of sclerosing cholangitis. Results in 178 patients. Ann Surg. 1990; 212(4):551-6; discussion 556-8. PMC: 1358296. DOI: 10.1097/00000658-199010000-00017. View

13.

Cho C, Dayton M, Thompson J, Koltun W, Heise C, Harms B . Proctocolectomy-ileal pouch-anal anastomosis for ulcerative colitis after liver transplantation for primary sclerosing cholangitis: a multi-institutional analysis. J Gastrointest Surg. 2008; 12(7):1221-6. DOI: 10.1007/s11605-008-0528-5. View

14.

Montano-Loza A, Bhanji R, Wasilenko S, Mason A . Systematic review: recurrent autoimmune liver diseases after liver transplantation. Aliment Pharmacol Ther. 2016; 45(4):485-500. DOI: 10.1111/apt.13894. View

15.

Trivedi P, Crothers H, Mytton J, Bosch S, Iqbal T, Ferguson J . Effects of Primary Sclerosing Cholangitis on Risks of Cancer and Death in People With Inflammatory Bowel Disease, Based on Sex, Race, and Age. Gastroenterology. 2020; 159(3):915-928. DOI: 10.1053/j.gastro.2020.05.049. View

16.

Brown S, Fearnhead N, Faiz O, Abercrombie J, Acheson A, Arnott R . The Association of Coloproctology of Great Britain and Ireland consensus guidelines in surgery for inflammatory bowel disease. Colorectal Dis. 2018; 20 Suppl 8:3-117. DOI: 10.1111/codi.14448. View

17.

Kulkarni C, Murag S, Cholankeril G, Fardeen T, Mannalithara A, Lerrigo R . Association of Anti-TNF Therapy With Increased Risk of Acute Cholangitis in Patients With Primary Sclerosing Cholangitis. Inflamm Bowel Dis. 2020; 27(10):1602-1609. DOI: 10.1093/ibd/izaa317. View

18.

Henson J, Patel Y, King L, Zheng J, Chow S, Muir A . Outcomes of liver retransplantation in patients with primary sclerosing cholangitis. Liver Transpl. 2016; 23(6):769-780. PMC: 5865072. DOI: 10.1002/lt.24703. View

19.

Moncrief K, Savu A, Ma M, Bain V, Wong W, Tandon P . The natural history of inflammatory bowel disease and primary sclerosing cholangitis after liver transplantation--a single-centre experience. Can J Gastroenterol. 2010; 24(1):40-6. PMC: 2830633. DOI: 10.1155/2010/830291. View

20.

Brandsaeter B, Broome U, Isoniemi H, Friman S, Hansen B, Schrumpf E . Liver transplantation for primary sclerosing cholangitis in the Nordic countries: outcome after acceptance to the waiting list. Liver Transpl. 2003; 9(9):961-9. DOI: 10.1053/jlts.2003.50169. View